CAS 41372-20-7
:Apomorphinhydrochlorid-Hemihydrat
- (R)-(-)-Apomorphine hydrochloride hemihydrate
- 4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate (2:1), (R)-
- 4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate (2:2:1), (6aR)-
- Apomorphine hydrochloride hemihydrate
- 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
- 4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, hydrate (2:1), (6aR)-
- 200-360-0
- (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
- (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride hydrate (2:2:1)
- Uprima
Apomorphine Hydrochloride Hemihydrate 1.0 mg/ml in Methanol (as anhydrous free base)
CAS:Farbe und Form:Single SolutionAPOMORPHINE HYDROCHLORIDE HEMIHYDRATE CRS
CAS:APOMORPHINE HYDROCHLORIDE HEMIHYDRATE CRSFormel:C17H17NO2Farbe und Form:RemovedMolekulargewicht:267.3224Apomorphine Hydrochloride
CAS:Drugs primarily affecting the central nervous system, nesoiFormel:C17H17NO2·HClH2OFarbe und Form:White Yellow Grey Crystalline PowderMolekulargewicht:312.79Apomorphine Hydrochloride Hemihydrate
CAS:Kontrolliertes ProduktFormel:C17H17NO2ClH·H2OFarbe und Form:NeatMolekulargewicht:625.58Apomorphine hydrochloride
CAS:Formel:C17H17NO2·HCl·5(H2O)Reinheit:≥ 98%Farbe und Form:White to grey powderMolekulargewicht:312.79(R)-Apomorphine Hydrochloride Hemihydrate
CAS:Kontrolliertes ProduktStability Hygroscopic, Light Sensitive
Applications Dopamine (D1 and D2) receptor agonist. Emetic. Antiparkinsonian.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Neumeyer, J.L., et al.: J. Pharm. Sci., 59, 1850 (1970), Ginos, J.Z., et al.: J. Med. Chem., 18, 1194 (1975), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 20, 121 (1991),Formel:C17H17NO2·2ClH·H2OFarbe und Form:NeatMolekulargewicht:625.58(R)-Apomorphine hydrochloride hemihydrate
CAS:Apomorphine hydrochloride is the salt form of apomorphine, a morphine derivative D2 dopamine agonist. The high selectivity for D2, D3, D4 and D5 receptors makes apomorphine hydrochloride a possible drug candidate and it is in clinical trials for diagnosis and treatment of Parkinsons disease. Moreover, apomorphine and apomorphine hydrochloride have been investigated in diverse studies for treating movement disorders.
Formel:C17H17NO2•HCl•(H2O)0Reinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:312.79 g/mol







